The human cell is wildly complex. Can AI decode it? | Silvana Konermann

Complex diseases like Alzheimer’s remain notoriously difficult to treat because each patient possesses a unique, tangled biological profile. Bioengineer and neuroscientist Silvana Konermann is addressing this challenge by developing a "universal virtual cell," an AI model designed to predict how cells respond to specific genetic or chemical interventions. By combining single-cell sequencing, CRISPR-based perturbations, and large-scale data generation—aiming for a billion physical experiments—this technology aims to replace traditional "guess and check" medicine with precise, data-driven therapeutic strategies. Unlike conventional pharmaceutical approaches that focus on single hypotheses, this model interprets the dynamic language of RNA to identify effective interventions across diverse patient profiles. By making this tool accessible to the global research community, the project seeks to accelerate breakthroughs in treating complex, multi-factorial diseases that have long stumped the medical field.